TRX-611: IBD
Novel approach to modulating anti-inflammatory response
TRX-813: Cancer
Reprofiling of poorly absorbed anthelmintic with tumour targeting
TRX-712: COPD
Preferential lung delivery for unexploited anti-inflammatory drug
TRX-914: Depression
Targeted brain delivery with clinically proven MoA
